The 10-second takeaway
For the quarter ended March 31 (Q1), Volcano missed estimates on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue grew. Non-GAAP earnings per share expanded. GAAP earnings per share.
Margins contracted across the board.
Volcano chalked up revenue of $93.2 million. The 16 analysts polled by S&P Capital IQ wanted to see a top line of $96.1 million on the same basis. GAAP reported sales were the same as the prior-year quarter's.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.02. The 11 earnings estimates compiled by S&P Capital IQ anticipated -$0.01 per share. Non-GAAP EPS of $0.02 for Q1 were much higher than the prior-year quarter's $0.00 per share. GAAP EPS were -$0.06 for Q1 compared to $0.00 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 64.5%, 280 basis points worse than the prior-year quarter. Operating margin was -0.2%, 230 basis points worse than the prior-year quarter. Net margin was -3.4%, 370 basis points worse than the prior-year quarter. (Margins calculated in GAAP terms.)
Next quarter's average estimate for revenue is $98.2 million. On the bottom line, the average EPS estimate is $0.00.
Next year's average estimate for revenue is $396.3 million. The average EPS estimate is $0.06.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 165 members out of 190 rating the stock outperform, and 25 members rating it underperform. Among 48 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 40 give Volcano a green thumbs-up, and eight give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Volcano is outperform, with an average price target of $27.53.
Is Volcano the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Volcano to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool recommends Volcano. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
Why Volcano Corporation's Shares Erupted Today
The beleaguered device-maker's fortunes turned around quickly with the arrival of a white knight from Europe.
Why Volcano Corporation Shares Temporarily Erupted
Volcano shares soar after reporting its first-quarter results. Find out if these results are buy-worthy or if investors should stick to the sidelines.
Can These 3 Diving Device Stocks Deliver in 2014?
Volcano, Intuitive Surgical, and Edwards Lifesciences have taken a hit this year. Should you trust that a turnaround is on the way?